Sugi Predict

Sugi Predict / Compounds / SCHEMBL553605

SCHEMBL553605

SCHEMBL553605

c1ccc(Cc2c[nH]c3ccccc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 1.00
▸ KMT2A Q03164 4/20 1.00
▸ AHR P35869 3/20 0.77
▸ CYP3A4 P08684 3/20 0.77
▸ GPR84 Q9NQS5 2/20 0.77
▸ MAPT P10636 2/20 0.77
▸ TDP1 Q9NUW8 1/20 0.77
▸ HTR6 P50406 2/20 0.74
▸ SLC6A2 P23975 1/20 0.60
▸ FNTA P49354 1/20 0.60
▸ FNTB P49356 1/20 0.60
▸ LMNA P02545 1/20 0.60
▸ GAA P10253 1/20 0.60
▸ TRPM8 Q7Z2W7 1/20 0.58
▸ TRPV1 Q8NER1 1/20 0.58
▸ MET P08581 1/20 0.57
▸ CYP2D6 P10635 3/20 0.56
▸ HTR2A P28223 2/20 0.56
▸ MPO P05164 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30648199 1.00 MEN1 (1.00) MEN1KMT2AAHRCYP3A4GPR84
Arundine SCHEMBL325162 0.87 MEN1 (1.00) MEN1KMT2AAHRCYP3A4GPR84
SCHEMBL5871352 0.85 MEN1 (0.74) MEN1KMT2AAHRCYP3A4GPR84
SCHEMBL1993893 0.85 MEN1 (0.74) MEN1KMT2AAHRCYP3A4GPR84
SCHEMBL3970092 0.85 MEN1 (0.74) MEN1KMT2AAHRCYP3A4GPR84
SCHEMBL5774387 0.85 MEN1 (0.74) MEN1KMT2AAHRCYP3A4GPR84
SCHEMBL16431661 0.85 MEN1 (0.74) MEN1KMT2AAHRCYP3A4GPR84
SCHEMBL3974807 0.85 MEN1 (0.74) MEN1KMT2AAHRCYP3A4GPR84
SCHEMBL4224120 0.85 HTR6 (1.00) MEN1KMT2AAHRCYP3A4GPR84
SCHEMBL147220 0.85 KMT2A (0.74) MEN1KMT2AAHRCYP3A4GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 — — US claimed
CN-115181054-B Synthesis method of 3-benzyl indole compound 合肥工业大学 2024-04-05 — — CN claimed
CN-115181054-A Synthetic method of 3-benzyl indole compound 合肥工业大学 2022-10-14 — — CN claimed
CN-114014859-A Triazole indolol compound and synthesis method thereof 绍兴文理学院 2022-02-08 — — CN claimed
US-9241944-B2 Methods and compositions for stimulating reepithelialisation during wound healing INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM) (FR) 2016-01-26 — — US claimed
CN-122036587-A Zalutst compound and application thereof in inhibiting MLL1-WDR5 interaction 暨南大学 2026-05-15 — — CN disclosed
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 — — US disclosed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 — — US disclosed
US-20240175141-A1 BIOBASED AND BIODEGRADABLE CORROSION INHIBITION COMPOSITION ZestBio, Inc. 2024-05-30 — — US disclosed
CN-115181054-B Synthesis method of 3-benzyl indole compound 合肥工业大学 2024-04-05 — — CN disclosed
CN-115181054-B Synthesis method of 3-benzyl indole compound 合肥工业大学 2024-04-05 — — CN disclosed
CN-115181054-B Synthesis method of 3-benzyl indole compound 合肥工业大学 2024-04-05 — — CN disclosed
EP-1571491-A1 Photothermographic material and method of forming images FUJI PHOTO FILM CO., LTD. (JP) 2005-09-07 — — EP disclosed
WO-2005068412-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 — — WO disclosed
US-20040198814-A1 Ketone compounds and compositions for cholesterol management and related uses ESPERION THERAPEUTICS, INC. 2004-10-07 — — US disclosed
US-20040058281-A1 Image forming method using photothermographic material FUJIFILM CORPORATION (JP) 2004-03-25 — — US disclosed
US-20040038156-A1 Image forming method using photothermographic material FUJIFILM CORPORATION (JP) 2004-02-26 — — US disclosed
US-20040018458-A1 Photothermographic material FUJIFILM CORPORATION (JP) 2004-01-29 — — US disclosed
US-5132319-A Antiasthmatic, antiinflammatory, antiallergen and cytoprotective agents MERCK FROSST CANADA, INC. (CA) 1992-07-21 — — US disclosed
US-4020068-A Chromogenic furoquinoxalines NCR CORPORATION (US) 1977-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 MEN1 2402/4885KMT2A 4633/4885AHR 1057/4885
US-20040198814-A1 Ketone compounds and compositions for cholesterol management and related uses PC, HMGCR, GPR119 MEN1 1965/4885KMT2A 1684/4885AHR 850/4885
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 MEN1 2402/4885KMT2A 4633/4885AHR 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.